An individual walks previous the Pfizer Headquarters constructing in New York, December 7, 2020.
Carlo Allegri | Reuters
The pattern of sturdy drug growth and inventory outperformance ought to proceed for Pfizer, making it a sensible guess for traders, in keeping with BMO Capital Markets.
